DQ3-58279-73305
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 014 / MA
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-07
Registered in v-safe
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
-
2021-03-15
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-03-23
- 2021-03-28
- 2021-04-03
- 2021-04-12
- 2021-04-19
- 2021-06-06
- 2021-09-06
-
2021-10-25
Dose 2 — ModernaCo-administered: yes
-
2021-11-11
Survey response — day 14, dose 2MedDRA: Headache, Lethargy, Nausea — Feeling: GoodFree text: Headache, Lethargic, nauseous.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-29
- 2022-01-26
- 2022-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-25 | Moderna | Yes |
Free text
Release 10 — day 14, dose 2
Symptoms: Headache, Lethargic, nauseous.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release